Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Piotr Koralewski"'
AMG 386 in combination with sorafenib in patients with metastatic clear cell carcinoma of the kidney
Autor:
Cezary Szczylik, Mayer Fishman, Yu Nien Sun, Andrzej Deptała, Piotr Koralewski, Karolyn Kracht, Bernard Escudier, Rodryg Ramlau, Brian I. Rini, Michael Bass, Luc Dirix, Alain Ravaud, Wojciech Rogowski, Markus Puhlmann, Nizar M. Tannir, Piotr Tomczak
Publikováno v:
Cancer. 118:6152-6161
Upregulation of proangiogenic factors in response to inactivation of the von Hippel-Lindau (VHL) gene is a critical component in the development and progression of clear cell renal cell carcinoma (RCC).1 Several inhibitors of the vascular endothelial
Autor:
Didier Debieuvre, Jean-Marc Limacher, Elisabeth Quoix, A. Madroszyk, Marc Buyse, Jean-Yves Bonnefoy, Z. Papai, Erich Stoelben, Gisèle Lacoste, Piotr Koralewski, Hervé Lena, Denis Braun, Alain Rivière, Marie-Pierre Chenard, Bérangère Bastien, Jean-Luc Breton, Annette Tavernaro, Rodryg Ramlau, Bruce Acres, Nadine Bizouarne, Virginie Westeel
Publikováno v:
Lancet Oncology
Lancet Oncology, Elsevier, 2011, 12 (12), pp.1125-1133. 〈10.1016/S1470-2045(11)70259-5〉
Lancet Oncology, Elsevier, 2011, 12 (12), pp.1125-1133. ⟨10.1016/S1470-2045(11)70259-5⟩
Lancet Oncology, Elsevier, 2011, 12 (12), pp.1125-1133. 〈10.1016/S1470-2045(11)70259-5〉
Lancet Oncology, Elsevier, 2011, 12 (12), pp.1125-1133. ⟨10.1016/S1470-2045(11)70259-5⟩
International audience; BACKGROUND: Chemotherapy is the standard of care for advanced stages of non-small-cell lung cancer (NSCLC). TG4010 is a targeted immunotherapy based on a poxvirus (modified vaccinia virus Ankara) that codes for MUC1 tumour-ass
Autor:
Heinz Ludwig, Anja H. Loos, A. Makhson, Carsten Bokemeyer, Gunter Schuch, Christopher Stroh, Serban Donea, A. Zubel, Joerg T. Hartmann, Igor Bondarenko, Jorge Aparicio, Filippo de Braud, Piotr Koralewski
Publikováno v:
Journal of Clinical Oncology. 27:663-671
Purpose This randomized study assessed whether the best overall response rate (ORR) of cetuximab combined with oxaliplatin, leucovorin, and fluorouracil (FOLFOX-4) was superior to that of FOLFOX-4 alone as first-line treatment for metastatic colorect
Autor:
Jean-Christophe Pouget, Maud Brandely, Piotr Koralewski, Mario Campone, Anna Tekiela, Isabelle Douville, Maria Blasinska-Morawiec
Publikováno v:
Cancer Chemotherapy and Pharmacology. 63:937-943
Combination of intravenous (i.v.) vinorelbine and docetaxel was shown to be feasible and effective in metastatic breast cancer (MBC). In an effort to improve patient convenience, we investigated in first-line treatment a regimen alternating i.v. and
Autor:
Alain Ravaud, Istvan Bodrogi, Agnieszka Jagiełło-Gruszfeld, Sergio Bracarda, Piotr Koralewski, Bernard Escudier, Bohuslav Melichar, Vera Gorbunova, Christine Chevreau, Marek Filipek, Anna Pluzanska, Cezary Szczylik, Emilio Bajetta, Jacques-Olivier Bay, Nicola Moore
Publikováno v:
The Lancet. 370:2103-2111
Summary Background Vascular endothelial growth factor (VEGF) inhibition is a valid therapeutic approach in renal cell carcinoma. Therefore, an investigation of the combination treatment of the humanised anti-VEGF monoclonal antibody bevacizumab with
Autor:
Christian Manegold, Jean-Yves Douillard, Patrick Peterson, Egbert F. Smit, William J. John, David R. Gandara, Coleman K. Obasaju, Luis Paz-Ares, Piotr Koralewski, Gee-Chen Chang, Michael Lahn, Jose Reyes
Publikováno v:
Journal of Clinical Oncology. 24:1428-1434
Purpose To determine whether aprinocarsen, an antisense oligonucleotide directed against protein kinase C-alpha, when added to the chemotherapy regimen of gemcitabine and cisplatin improved survival in patients with advanced non–small-cell lung can
Autor:
Olena O. Kolesnik, Angelika Lahr, Carsten Bokemeyer, Pawel Murawa, Alexander Burges, Arturas Razbadauskas, Elena Ganea-Motan, Piotr Koralewski, Horst Lindhofer, Tudor Ciuleanu, Pauline Wimberger, Martin Gore, Birute Aleknaviciene, Elzbieta Kutarska, Markus M. Heiss, Alexander Schmittel, Alexander S. Dudnichenko, Simon L. Parsons, Barbara Schmalfeldt, Vladimir V. Ivanchenko
Publikováno v:
International Journal of Cancer. Journal International du Cancer
Malignant ascites is a common manifestation of advanced cancers, and treatment options are limited. The trifunctional antibody catumaxomab (anti-epithelial cell-adhesion molecule x anti-CD3) represents a targeted immunotherapy for the intraperitoneal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::393a7a13863f9f8e2e916f095de728a2
https://www.ncbi.nlm.nih.gov/pubmed/20473913
https://www.ncbi.nlm.nih.gov/pubmed/20473913
Autor:
Armin Schueler, Nadia Amellal, Piotr Koralewski, Rainald Knecht, Ricardo Hitt, Jan B. Vermorken, José Baselga, Jose Manuel Trigo, Frederic Rolland, Eduardo Díaz-Rubio
Publikováno v:
Journal of clinical oncology
Purpose To evaluate the efficacy and safety of the epidermal growth factor receptor–directed monoclonal antibody cetuximab administered as a single agent in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck (SCC
Publikováno v:
Arzneimittel-Forschung. 51(7)
The pharmacokinetics and toxicity of (-)-(S)-bromofosfamide ((2S)-(2-chloroethylamino)-3-(2-bromoethyl)-1,3,2-oxazaphosphorinae 2-oxide, CAS 146452-37-1, CBM-11) were determined in ten patients with non-small cell lung cancer following an oral dose o